A detailed history of First Trust Advisors LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Advisors LP holds 402,300 shares of IONS stock, worth $13.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
402,300
Previous 16,194 2384.25%
Holding current value
$13.7 Million
Previous $771,000 1990.27%
% of portfolio
0.02%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.06 - $51.86 $15.5 Million - $20 Million
386,106 Added 2384.25%
402,300 $16.1 Million
Q2 2024

Aug 13, 2024

SELL
$36.45 - $47.7 $5.82 Million - $7.62 Million
-159,664 Reduced 90.79%
16,194 $771,000
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $38.7 Million - $49.4 Million
-921,872 Reduced 83.98%
175,858 $7.62 Million
Q4 2023

Feb 13, 2024

SELL
$43.39 - $51.63 $1.62 Million - $1.92 Million
-37,249 Reduced 3.28%
1,097,730 $55.5 Million
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $7.24 Million - $8.86 Million
-188,053 Reduced 14.21%
1,134,979 $51.5 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $11 Million - $13.7 Million
-315,911 Reduced 19.28%
1,323,032 $54.3 Million
Q1 2023

May 15, 2023

SELL
$33.58 - $41.2 $4.77 Million - $5.85 Million
-141,990 Reduced 7.97%
1,638,943 $58.6 Million
Q4 2022

Feb 09, 2023

SELL
$37.12 - $46.52 $11 Million - $13.8 Million
-296,327 Reduced 14.27%
1,780,933 $67.3 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $17.6 Million - $23.4 Million
481,205 Added 30.15%
2,077,260 $91.9 Million
Q2 2022

Aug 12, 2022

SELL
$31.71 - $43.0 $641,651 - $870,105
-20,235 Reduced 1.25%
1,596,055 $59.1 Million
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $1.9 Million - $2.36 Million
-63,722 Reduced 3.79%
1,616,290 $59.9 Million
Q4 2021

Feb 08, 2022

SELL
$25.61 - $35.1 $13,752 - $18,848
-537 Reduced 0.03%
1,680,012 $51.1 Million
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $5.3 Million - $6.41 Million
158,100 Added 10.38%
1,680,549 $56.4 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $12.2 Million - $16.8 Million
354,640 Added 30.37%
1,522,449 $60.7 Million
Q1 2021

May 14, 2021

SELL
$42.51 - $63.78 $9.31 Million - $14 Million
-219,122 Reduced 15.8%
1,167,809 $52.5 Million
Q4 2020

Feb 02, 2021

SELL
$45.3 - $60.27 $488,424 - $649,831
-10,782 Reduced 0.77%
1,386,931 $78.4 Million
Q3 2020

Nov 05, 2020

BUY
$47.45 - $62.95 $3.91 Million - $5.19 Million
82,506 Added 6.27%
1,397,713 $66.3 Million
Q2 2020

Jul 22, 2020

BUY
$46.85 - $61.05 $17 Million - $22.1 Million
362,734 Added 38.08%
1,315,207 $77.5 Million
Q1 2020

May 06, 2020

SELL
$41.6 - $63.4 $1.94 Million - $2.95 Million
-46,605 Reduced 4.66%
952,473 $45 Million
Q4 2019

Feb 03, 2020

BUY
$53.85 - $65.27 $547,223 - $663,273
10,162 Added 1.03%
999,078 $60.4 Million
Q3 2019

Nov 04, 2019

SELL
$59.06 - $72.15 $41.3 Million - $50.5 Million
-699,359 Reduced 41.42%
988,916 $59.2 Million
Q2 2019

Jul 30, 2019

SELL
$62.09 - $86.14 $56.1 Million - $77.8 Million
-903,564 Reduced 34.86%
1,688,275 $109 Million
Q1 2019

May 09, 2019

BUY
$52.92 - $81.17 $19.6 Million - $30.1 Million
370,977 Added 16.7%
2,591,839 $210 Million
Q4 2018

Feb 07, 2019

BUY
$43.37 - $59.54 $4.13 Million - $5.66 Million
95,138 Added 4.48%
2,220,862 $120 Million
Q3 2018

Oct 25, 2018

BUY
$42.88 - $53.7 $45.4 Million - $56.8 Million
1,057,960 Added 99.08%
2,125,724 $110 Million
Q2 2018

Aug 02, 2018

BUY
$40.53 - $50.7 $1.6 Million - $2 Million
39,452 Added 3.84%
1,067,764 $44.5 Million
Q1 2018

Apr 23, 2018

BUY
$44.08 - $55.05 $4.24 Million - $5.3 Million
96,291 Added 10.33%
1,028,312 $45.3 Million
Q4 2017

Feb 08, 2018

SELL
$50.3 - $64.39 $2.53 Million - $3.24 Million
-50,323 Reduced 5.12%
932,021 $46.9 Million
Q3 2017

Oct 24, 2017

BUY
$45.56 - $59.57 $44.8 Million - $58.5 Million
982,344
982,344 $49.8 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.